NCT02436343

Brief Summary

The aim of this work is to Assess serial changes in "cardiovascular function" in morbidly obese pregnant females (BMI equal or higher than 30 kg/m2) as compared to normal lean pregnant female controls.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2015

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 2, 2015

Completed
4 days until next milestone

First Posted

Study publicly available on registry

May 6, 2015

Completed
26 days until next milestone

Study Start

First participant enrolled

June 1, 2015

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2017

Completed
Last Updated

July 11, 2018

Status Verified

July 1, 2018

Enrollment Period

2.2 years

First QC Date

May 2, 2015

Last Update Submit

July 10, 2018

Conditions

Keywords

left ventricular functionspregnancyobesity

Outcome Measures

Primary Outcomes (1)

  • cardiac performance

    the cardiac performance (the left ventricular functions) in obese and lean pregnant women throughout each trimester and six weeks postpartum.

    2 hours

Secondary Outcomes (6)

  • The prevalence of cardiac lesions.

    2 hours

  • The need of any medications among obese pregnant women

    9 months

  • The need of any advanced investigation among obese pregnant women

    9 months

  • The need of hospitalization among obese pregnant women

    9 months

  • The need of termination of pregnancy among obese pregnant women

    9 months

  • +1 more secondary outcomes

Study Arms (2)

obese pregnant women

pregnant women wit body mass index more than or equal to 30 kg/m2 will be subjected to four serial echocardiograms in the 3 trimesters of pregnancy and in the postpartum state. Height, weight, systolic and diastolic blood pressures will be measured at each echocardiographic evaluation.

Other: echocardiogram

lean pregnant women

pregnant women wit body mass index less than or equal to 25kg/m2 will be subjected to four serial echocardiograms in the 3 trimesters of pregnancy and in the postpartum state. Height, weight, systolic and diastolic blood pressures will be measured at each echocardiographic evaluation.

Other: echocardiogram

Interventions

At each echocardiographic evaluation, the investigator will obtain the following parameters: Left ventricular internal dimensions at end diastole Left ventricular posterior wall thickness Left ventricular end systolic stress Left ventricular fractional shortening Velocity of circumferential shortening Left ventricular mass Contractility and indices of preload Stroke volume

lean pregnant womenobese pregnant women

Eligibility Criteria

Age20 Years - 35 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

Any pregnant woman in her 1st trimester with a singleton live healthy pregnancy will be eligible for inclusion in the study. Eligible women will be further categorized into case and control groups. Women with body mass index equals or more than 30kg/m2 will be considered case. Control women will be with BMI equals or less than 25 kg/m2.

You may qualify if:

  • Any pregnant woman in her 1st trimester with a singleton live healthy pregnancy

You may not qualify if:

  • Multiple gestations.
  • Anemia.
  • Medical history of hypertension.
  • Medical history of any cardiac disease.
  • Medical history of pre-gestational diabetes.
  • Development of gestational diabetes and pre-eclampsia.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

antenatal clinic of Armed Forces Hospital, Southern Region

Khamis Mushait, 'Asir Region, 101, Saudi Arabia

Location

MeSH Terms

Conditions

Obesity

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • ahmed altraigey

    Benha University

    STUDY DIRECTOR
  • haytham attya

    Zagazig University

    PRINCIPAL INVESTIGATOR
  • nuzhat amer

    Armed Forces Hospitals, Southern Region, Saudi Arabia

    PRINCIPAL INVESTIGATOR
  • Mohamed Kolkailah

    Armed Forces Hospitals, Southern Region, Saudi Arabia

    STUDY CHAIR
  • mohammed mesilhy

    Armed Forces Hospitals, Southern Region, Saudi Arabia

    PRINCIPAL INVESTIGATOR
  • mohammed attia

    Armed Forces Hospitals, Southern Region, Saudi Arabia

    PRINCIPAL INVESTIGATOR
  • mohammed shehri

    Armed Forces Hospitals, Southern Region, Saudi Arabia

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
lecturer

Study Record Dates

First Submitted

May 2, 2015

First Posted

May 6, 2015

Study Start

June 1, 2015

Primary Completion

August 1, 2017

Study Completion

August 1, 2017

Last Updated

July 11, 2018

Record last verified: 2018-07

Data Sharing

IPD Sharing
Will not share

Locations